• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    2/10/23 1:22:43 PM ET
    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Beverages (Production/Distribution)
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABEV alert in real time by email

     

    During Friday, 48 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Ambev (NYSE:ABEV).
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Soligenix (NASDAQ:SNGX) shares traded down 1193.45% to reach its 52-week low, making it the biggest loser.
    • Vertical Aerospace (NYSE:EVTL) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Ambev (NYSE:ABEV) stock achieved a new 52-week low on Friday morning, hitting $2.41 and moving down 1.43%.
    • Bank Bradesco (NYSE:BBD) stock hit a yearly low of $2.43. The stock was down 6.98% for the day.
    • Sirius XM Holdings (NASDAQ:SIRI) shares were down 0.42% for the day, having made a 52-week low of $4.72.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.60. The stock traded down 0.79%.
    • Sterling Check (NASDAQ:STER) shares set a new yearly low of $11.92 this morning. The stock was down 11.46% on the session.
    • Cronos Group (NASDAQ:CRON) shares made a new 52-week low of $2.26 on Friday. The stock was down 1.72% for the day.
    • Mercer Intl (NASDAQ:MERC) shares fell to $10.55 on Friday, setting a new 52-week low with a shift of down 10.52%.
    • Azul (NYSE:AZUL) stock hit $5.19 on Friday morning, setting a new 52-week low for a change of down 4.59%.
    • Vertical Aerospace (NYSE:EVTL) stock hit a yearly low of $1.94. The stock was 0.0% (flat) for the day.
    • Bridger Aerospace Gr (NASDAQ:BAER) stock hit a new 52-week low of $3.77. The stock was down 2.18% on the session.
    • Guaranty Bancshares (NASDAQ:GNTY) shares hit a yearly low of $31.10. The stock was up 0.09% on the session.
    • Hyzon Motors (NASDAQ:HYZN) shares reached a new 52-week low of $1.25 on Friday morning, moving down 23.94%.
    • Tupperware Brands (NYSE:TUP) shares reached a new 52-week low of $3.72 on Friday morning, moving down 1.28%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) shares fell to $1.10 on Friday, setting a new 52-week low with a shift of down 6.38%.
    • GreenLight Biosciences (NASDAQ:GRNA) stock hit $0.86 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a yearly low of $2.04. The stock was down 6.11% for the day.
    • Clough Global Equity (AMEX:GLQ) shares hit a yearly low of $6.14. The stock was up 0.33% on the session.
    • Vintage Wine Estates (NASDAQ:VWE) stock achieved a new 52-week low on Friday morning, hitting $1.85 and moving down 5.48%.
    • Heliogen (NYSE:HLGN) stock set a new 52-week low of $0.38 on Friday, moving down 8.33%.
    • NeoVolta (NASDAQ:NEOV) shares set a new yearly low of $1.96 this morning. The stock was down 7.11% on the session.
    • Taysha Gene Therapies (NASDAQ:TSHA) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 2.38%.
    • P3 Health Partners (NASDAQ:PIII) stock achieved a new 52-week low on Friday morning, hitting $1.05 and moving down 4.0%.
    • 9F (NASDAQ:JFU) stock dropped to a yearly low on Friday of $3.13. Shares traded down 8.92%.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares moved down 2.09% on Friday to hit a new 52-week low of $0.80, drifting down 2.09%.
    • MGO Global (NASDAQ:MGOL) shares set a new 52-week low of $1.79. The stock traded down 9.05%.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock broke to a new 52-week low of $1.86 on Friday. Shares of the company traded down 0.1%.
    • CN Energy Group (NASDAQ:CNEY) shares set a new yearly low of $0.41 this morning. The stock was down 6.33% on the session.
    • Can Fite Biofarma (AMEX:CANF) shares set a new yearly low of $3.35 this morning. The stock was down 4.23% on the session.
    • WiSA Technologies (NASDAQ:WISA) stock achieved a new 52-week low on Friday morning, hitting $5.99 and moving down 4.31%.
    • Tenax Therapeutics (NASDAQ:TENX) shares fell to $1.03 on Friday, setting a new 52-week low with a shift of down 2.73%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares reached a new 52-week low of $1.23 on Friday morning, moving down 7.95%.
    • OceanPal (NASDAQ:OP) stock hit a new 52-week low of $0.62. The stock was down 10.98% on the session.
    • OpGen (NASDAQ:OPGN) stock hit a new 52-week low of $1.45. The stock was down 4.97% on the session.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.18 on Friday morning, moving down 1.76%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares hit a yearly low of $5.10. The stock was down 5.06% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ABEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $ALLR
    $ASTI
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Taysha Gene Therapies Inc.
    $TSHA
    10/21/2025$13.00Strong Buy
    Raymond James
    Banco Bradesco Sa
    $BBD
    10/14/2025Sell → Neutral
    Goldman
    NeoVolta Inc.
    $NEOV
    10/1/2025Buy → Hold
    Maxim Group
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Ambev S.A.
    $ABEV
    8/1/2025Buy → Hold
    HSBC Securities
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    More analyst ratings

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    SEC Filings

    View All

    SEC Form 10-Q filed by Cronos Group Inc.

    10-Q - Cronos Group Inc. (0001656472) (Filer)

    11/6/25 7:34:16 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cronos Group Inc. (0001656472) (Filer)

    11/6/25 7:32:50 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Hanesbrands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hanesbrands Inc. (0001359841) (Filer)

    11/6/25 7:03:33 AM ET
    $HBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascent Solar Technologies and CisLunar Industries Enter Teaming Agreement to Bring Power Solutions that Lengthen Missions to U.S. Space Market

    THORNTON, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies ("Ascent"), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced the signing of a teaming agreement with CisLunar Industries ("CisLunar"), a leader in developing advanced hardware and embedded control software for power conversion and conditioning. The agreement aims to bring each of the Colorado-based companies' technologies together to achieve mutually beneficial spaceflight goals that support their competitive positioning for current and future space missions with various U.S. space organizations including NASA, the Departm

    11/6/25 8:00:00 AM ET
    $ASTI
    Semiconductors
    Technology

    Vertical Aerospace Provides Third Quarter Update, Demonstrating Momentum on Transition Flight Testing, Business Plan Updates and Best-in-Class Aircraft

    Vertical will imminently enter piloted transition flight test phase First look at new certification aircraft's leading cabin size and comfort Board strengthened with appointment of former EASA Director General, Patrick Ky to the Company's Board of Directors Q3 2025 Business & Strategy Update call today at 08:30 am ET (13:30 GMT) Vertical Aerospace (NYSE:EVTL) ("Vertical," "we," "our" or the "Company"), a global aerospace and technology company that is pioneering electric aviation, will today provide its Business & Strategy Update for the third quarter of 2025. The filing of our Q3 2025 financial results is accessible on the Company's investor relations website. Transition Flight:

    11/4/25 7:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    TSHA-102 granted Breakthrough Therapy designation by FDA Finalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month interim analysis that may expedite BLA submission, which was enabled by the rigorous developmental milestone evaluation in Part A REVEAL Phase 1/2 trials showing an unprecedented response rate Dosing of first patient in REVEAL pivotal trial scheduled for Q4 2025, with enrollment of additional patients expected to continue at multiple sites this quarter Presented new supplemental analysis of Part A REVEAL data reinforcing the broad and consistent, multi-domain impact of TSHA-102 on activities of daily living at the CNS Annual Meeting TSHA-102

    11/4/25 7:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN, CEO AND PRESIDENT Schaber Christopher J bought $20,000 worth of shares (15,132 units at $1.32), increasing direct ownership by 3,993% to 15,511 units (SEC Form 4)

    4 - SOLIGENIX, INC. (0000812796) (Issuer)

    10/3/25 1:18:09 PM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Welty Linda J bought $30,866 worth of shares (10,000 units at $3.09), increasing direct ownership by 38% to 36,290 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/19/25 12:23:28 PM ET
    $MERC
    Paper
    Basic Materials

    Director Laberge Alice bought $5,957 worth of shares (2,000 units at $2.98), increasing direct ownership by 20% to 12,065 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/8/25 5:50:55 PM ET
    $MERC
    Paper
    Basic Materials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Salen Kristina sold $39,926 worth of shares (1,845 units at $21.64), decreasing direct ownership by 8% to 19,969 units (SEC Form 4)

    4 - SIRIUS XM HOLDINGS INC. (0000908937) (Issuer)

    11/4/25 4:05:47 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    CEO and Chairman Pham Quang X sold $34,237 worth of shares (2,444 units at $14.01), decreasing direct ownership by 1% to 196,089 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    10/28/25 5:00:02 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Szot Matthew K sold $50,364 worth of shares (3,600 units at $13.99), decreasing direct ownership by 27% to 9,933 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    10/28/25 5:00:04 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Taysha Gene Therapies with a new price target

    Raymond James initiated coverage of Taysha Gene Therapies with a rating of Strong Buy and set a new price target of $13.00

    10/21/25 7:22:35 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Banco Bradesco upgraded by Goldman

    Goldman upgraded Banco Bradesco from Sell to Neutral

    10/14/25 8:35:27 AM ET
    $BBD
    Major Banks
    Finance

    NeoVolta downgraded by Maxim Group

    Maxim Group downgraded NeoVolta from Buy to Hold

    10/1/25 8:19:55 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Vertical Aerospace Provides Third Quarter Update, Demonstrating Momentum on Transition Flight Testing, Business Plan Updates and Best-in-Class Aircraft

    Vertical will imminently enter piloted transition flight test phase First look at new certification aircraft's leading cabin size and comfort Board strengthened with appointment of former EASA Director General, Patrick Ky to the Company's Board of Directors Q3 2025 Business & Strategy Update call today at 08:30 am ET (13:30 GMT) Vertical Aerospace (NYSE:EVTL) ("Vertical," "we," "our" or the "Company"), a global aerospace and technology company that is pioneering electric aviation, will today provide its Business & Strategy Update for the third quarter of 2025. The filing of our Q3 2025 financial results is accessible on the Company's investor relations website. Transition Flight:

    11/4/25 7:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    NeoVolta Enters Into Asset Purchase Agreement for Neubau Energy's Next-Generation Battery Platform; Expects Transaction to Be Immediately Accretive to Revenues and Gross Margins

    SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ:NEOV) entered into on October 1, 2025 an asset purchase agreement for the purchase of strategic assets of Neubau Energy pursuant to its letter of intent announced on September 10, 2025 [link]. The acquisition is expected to close by October 15, 2025. Concurrently, NeoVolta hired Neubau executives, naming Amany Ibrahim as chief operating officer and Thomas Enzendorfer as chief technology officer. Michael Mendik, the company's previous chief operating officer, will continue with the company and serve as its chief product officer. "Merging Neubau's talent and next-gen battery manufacturing platform is a significant milestone

    10/7/25 7:05:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    CISO Global Strengthens Balance Sheet, Positions for Growth and Strategic Opportunities

    Scottsdale, AZ, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ:CISO) a leading provider of AI-powered cybersecurity software and compliance services, today announced it is well-positioned to accelerate sales growth and pursue strategic opportunities following significant steps to strengthen its balance sheet. The Company recently exchanged the last remaining investor debt into Preferred A shares, with no associated warrants. This transaction eliminated more than $9 million in debt, moving it to equity now held by two long-term supporters of CISO Global. Earlier this week, CISO Global announced a financing agreement with B. Riley that provides up to $15 million in potential growth

    10/1/25 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    TSHA-102 granted Breakthrough Therapy designation by FDA Finalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month interim analysis that may expedite BLA submission, which was enabled by the rigorous developmental milestone evaluation in Part A REVEAL Phase 1/2 trials showing an unprecedented response rate Dosing of first patient in REVEAL pivotal trial scheduled for Q4 2025, with enrollment of additional patients expected to continue at multiple sites this quarter Presented new supplemental analysis of Part A REVEAL data reinforcing the broad and consistent, multi-domain impact of TSHA-102 on activities of daily living at the CNS Annual Meeting TSHA-102

    11/4/25 7:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HanesBrands Announces Reporting Date for Third Quarter Fiscal 2025 Financial Results

    HanesBrands Inc. (NYSE:HBI) today announced that it plans to report its third quarter fiscal 2025 financial results on Thursday, November 6, 2025, before the market opens via press release. Given the pending acquisition of HanesBrands Inc. by Gildan Activewear Inc., announced in August 2025, HanesBrands will not hold a conference call. The press release will be available in the Investors section of the HanesBrands corporate website at www.hanes.com/investors. About HanesBrands HanesBrands (NYSE:HBI), the No. 1 seller of innerwear, is a socially responsible global leader in everyday iconic apparel with a mission to create a more comfortable world for every body. The company owns a port

    10/30/25 8:30:00 AM ET
    $HBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Bridger Aerospace Announces Schedule for its Third Quarter 2025 Earnings Release and Conference Call

    BELGRADE, Mont., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. ("Bridger" or "Bridger Aerospace"), (NASDAQ:BAER, BAERW)), one of the nation's largest aerial firefighting companies, today announced that it will release financial results for the third quarter ended September 30, 2025 on Thursday, November 6, 2025, after the market close. Management will conduct an investor conference call on Thursday, November 6 at 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time) to discuss these results and the business outlook. Interested parties can access the conference call by dialing 1-800-343-4136 or 1-203-518-9843. The conference call will also be broadcast live on the Inv

    10/30/25 8:05:00 AM ET
    $BAER
    Real Estate